1. Home
  2. ETON vs GLAD Comparison

ETON vs GLAD Comparison

Compare ETON & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$27.17

Market Cap

683.7M

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

HOLD

Current Price

$18.99

Market Cap

395.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
GLAD
Founded
2017
2001
Country
United States
United States
Employees
N/A
65
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
683.7M
395.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
GLAD
Price
$27.17
$18.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$39.33
$22.33
AVG Volume (30 Days)
465.8K
237.4K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
9.70%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$79,950,000.00
N/A
Revenue This Year
$40.90
$15.16
Revenue Next Year
$47.23
$5.10
P/E Ratio
N/A
$11.70
Revenue Growth
104.94
N/A
52 Week Low
$13.09
$16.54
52 Week High
$27.19
$29.50

Technical Indicators

Market Signals
Indicator
ETON
GLAD
Relative Strength Index (RSI) 71.85 61.33
Support Level $16.23 $18.84
Resistance Level N/A $19.93
Average True Range (ATR) 1.19 0.57
MACD 0.06 0.18
Stochastic Oscillator 93.17 96.31

Price Performance

Historical Comparison
ETON
GLAD

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

Share on Social Networks: